Pregnancy Category: C
Topical treatment of interdigital tinea pedis, tinea cruris and tinea corporis.
Inhibits an enzyme necessary for ergosterol synthesis, required for fungal cell membranes.
Resolution of dermal fungal infection.Active against Trichyphyton rubrum and Epidermpophyton floccosum.
Absorption: Small amounts are systemically absorbed.
Protein Binding: >99%
Metabolism and Excretion: Unknown.
Time/action profile (improvement/resolution of infection)
Contraindicated in: None noted;
Use Cautiously in: Obstetric: Use in pregnancy only if potential benefit justifies any fetal risks; Lactation: Use cautiously in breast feeding women. Pediatric: Safe and effective use in children <18 yr not established.
Adverse Reactions/Side Effects
- application site reactions
Drug-Drug interactionMay inhibit the activity of the CYP3A4 and CYP2C19 enzymes.
Topical (Adults) Interdigital tinea pedisApply to affected and surrounding areas once daily for two weeks; Tinea cruris and tinea corporisApply to affected and surrounding areas once daily for one week.
Topical cream: 1%
- Inspect involved areas of skin and mucous membranes before and frequently during therapy. Increased skin irritation may indicate need to discontinue medication.
Potential Nursing DiagnosesRisk for impaired skin integrity (Indications)
Risk for infection (Indications)
- Consult health care professional for proper cleansing technique before applying medication.
- Topical: For Interdigital tinea pedis: Apply thin layer to cover affected area and approximately 1 inch of immediate surrounding area completely daily for 2 wk.
- For Tinea Cruris or Tinea Corporis: Apply thin layer to affected area and approximately 1 inch of immediate surrounding area daily for 1 wk.
- Avoid the use of occlusive wrappings or dressings unless directed by health care professional. Wash hands after application.
- Instruct patient to apply medication as directed for full course of therapy, even if feeling better. Emphasize the importance of avoiding the eyes and vagina.
- Patients with athlete’s foot should be taught to wear well-fitting, ventilated shoes, to wash affected areas thoroughly, and to change shoes and socks at least once a day.
- Advise patient to report increased skin irritation or lack of response to therapy to health care professional.
- Instruct patient to notify health care professional of all Rx or OTC medications, vitamins, or herbal products being taken and consult health care professional before taking any new medications.
- Advise female patient to notify health care professional if pregnancy is planned or suspected or if breastfeeding.
- Decrease in skin irritation and resolution of infection.
Drug Guide, © 2015 Farlex and Partners